CYP26A1 and colorectal cancer: The CYP26 enzymes have been proposed as anti-cancer drug targets [65] and the increased expression of CYP26A1 and CYP26B1 in colorectal cancer would suggest that these enzymes may be relevant therapeutic targets in this type of tumours.